Denali Advisors LLC Biogen Inc. Transaction History

Denali Advisors LLC

$916 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$212.02 - $267.71 $84,808 - $107,083	400 New	400 $86,000
Q2 2023 Jul 18, 2023	SELL	$275.25 - $318.06 $413,700 - $478,044	-1,503 Reduced 62.55%	900 $256,000
Q1 2023 Apr 21, 2023	BUY	$256.56 - $292.34 $77,737 - $88,579	303 Added 14.43%	2,403 $668,000
Q4 2022 Feb 09, 2023	SELL	$252.44 - $306.72 $328,172 - $398,736	-1,300 Reduced 38.24%	2,100 $581,000
Q3 2022 Oct 25, 2022	BUY	$194.69 - $268.46 $330,973 - $456,381	1,700 Added 100.0%	3,400 $908,000
Q2 2022 Jul 18, 2022	BUY	$187.54 - $223.02 $18,754 - $22,302	100 Added 6.25%	1,700 $347,000
Q1 2022 Apr 19, 2022	BUY	$193.77 - $244.14 $116,262 - $146,484	600 Added 60.0%	1,600 $336,000
Q4 2021 Jan 21, 2022	BUY	$223.92 - $287.77 $111,960 - $143,885	500 Added 100.0%	1,000 $240,000
Q3 2021 Oct 12, 2021	SELL	$282.99 - $369.05 $28,299 - $36,905	-100 Reduced 16.67%	500 $141,000
Q2 2021 Aug 20, 2021	SELL	$259.0 - $414.71 $543,900 - $870,891	-2,100 Reduced 77.78%	600 $208,000
Q1 2021 Apr 26, 2021	SELL	$242.95 - $284.63 $3.3 Million - $3.87 Million	-13,600 Reduced 83.44%	2,700 $755,000
Q4 2020 Jan 20, 2021	SELL	$236.26 - $355.63 $425,268 - $640,134	-1,800 Reduced 9.94%	16,300 $3.99 Million
Q3 2020 Oct 16, 2020	BUY	$264.77 - $305.71 $4.53 Million - $5.23 Million	17,100 Added 1710.0%	18,100 $5.14 Million
Q2 2020 Jul 23, 2020	BUY	$258.66 - $342.55 $258,660 - $342,550	1,000 New	1,000 $268,000
Q1 2020 Apr 23, 2020	SELL	$268.85 - $341.04 $994,745 - $1.26 Million	-3,700 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$220.06 - $304.07 $3.37 Million - $4.65 Million	-15,300 Reduced 80.53%	3,700 $1.1 Million
Q3 2019 Oct 09, 2019	BUY	$217.44 - $243.88 $1.7 Million - $1.9 Million	7,800 Added 69.64%	19,000 $4.42 Million
Q2 2019 Jul 08, 2019	BUY	$219.29 - $241.72 $2.46 Million - $2.71 Million	11,200 New	11,200 $2.62 Million
Q1 2018 Apr 23, 2018	SELL	$260.13 - $367.91 $130,065 - $183,955	-500 Closed	0 $0
Q4 2017 Jan 24, 2018	BUY	$307.64 - $344.58 $153,820 - $172,290	500	500 $159,000

Others Institutions Holding BIIB

# of Institutions

1,035

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.

Account